EU Medicines Agency

@EMA_News

Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.

Vrijeme pridruživanja: veljača 2010.

Tweetovi

Blokirali ste korisnika/cu @EMA_News

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EMA_News

  1. 4. velj

    To contribute to the global response to the outbreak of the novel infections, EMA is taking concrete actions to accelerate the development and availability of medicinal products for the treatment and prevention of the new coronavirus:

    Poništi
  2. 4. velj

    EMA shares the priorities on improving prevention and care, and is committed to supporting the Commission and during the development of the future cancer plan. .

    Poništi
  3. 4. velj

    Tutti dobbiamo assumere delle 💊 ad un certo punto della nostra vita. Conosci il percorso di una medicina valutata dall'EMA? Dai un'occhiata alla brochure che spiega come una medicina arriva dal laboratorio al paziente, che è ora disponibile in italiano. ➡️

    Poništi
  4. 4. velj

    Irgendwann müssen fast alle 💊💊einnehmen. Aber wie bewertet die EMA ob sie sicher sind und wirken? Eine neue Broschüre erklärt den Weg eines Arzneimittels vom Labor zum , jetzt auch auf Deutsch. ➡️

    Poništi
  5. 4. velj

    Nous devons tous prendre des 💊💊à un moment de notre vie. Savez-vous quel est le parcours emprunté par un médicament évalué par l’EMA ? Pour cela, lisez notre brochure expliquant comment un médicament va du laboratoire au : ➡️

    Poništi
  6. 3. velj

    We gathered today to raise the EU flags in the lobby of EMA’s new and final building in Amsterdam:

    Poništi
  7. 31. sij

    UK withdrawal from the EU on 31 January 2020: During the transition period, EU pharmaceutical law will continue to be applicable to the UK, meaning that pharmaceutical companies can continue to carry out activities in the UK until the end of the year. 👉

    Poništi
  8. 31. sij

    First oral GLP-1 treatment for type 2 recommended for approval. It provides patients with an option to treat the disease without injections

    Poništi
  9. 31. sij

    First treatment for , a rare life-threatening genetic condition, recommended for approval

    Poništi
  10. 31. sij
    Poništi
  11. proslijedio/la je Tweet
    27. sij
    Poništi
  12. 29. sij

    Today we have published the key principles for the use of electronic product information () for EU medicines. Read what benefits ePI can deliver for : ➡️

    Poništi
  13. 28. sij

    Are you a in the EU? You can now check EMA's updated scientific advice on the categorisation of antibiotics when prescribing these medicines for animals in your care: 👉

    Poništi
  14. 27. sij

    This week marks EMA’s 25th anniversary. Learn more about the key milestones and achievements in the authorisation and safety monitoring of for human and animal use in the EU since EMA’s establishment in 1995: 👉

    Poništi
  15. 27. sij

    What's on the agenda of the January meeting of EMA's human medicines committee

    Poništi
  16. 24. sij

    At its January meeting, EMA’s Committee for Advanced Therapies (CAT) re-elected Dr Martina Schüssler-Lenz as its chair, for a second three-year mandate. Congratulations! 👉

    Poništi
  17. proslijedio/la je Tweet

    🆕 We welcome today's ruling confirming public access to clinical study trials. ⚖️ judgement 👉 We worked with over many years for greater transparency in this area 👇

    Poništi
  18. 22. sij

    The Court of Justice () upholds EMA’s approach to transparency:

    Poništi
  19. 20. sij

    Find out more about the top-ten recommendations of the HMA-EMA Joint task force, which includes establishing an EU platform to access and analyse healthcare data from across the EU, called ‘DARWIN’. 👉

    Poništi
  20. 20. sij

    The HMA-EMA Joint Big Data task force proposes ten priority actions to unlock the potential of big data for public health in the EU

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·